For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

The J. David Gladstone Institutes

Calculating rank

USPTO Granted Patents = 91

% Expired Patents = 27.5

CIPO Patents = 6

EPO Patents = 25

Trademarks = 2

Forward Citations = 254

Loading Chart...

Loading Chart...

136 inventors (with patents filed for the assignee):

Eric M Verdin (17 out of 23 patents)

Yadong Huang (11 out of 14 patents)

Warner C Greene (9 out of 15 patents)

4. Lennart Mucke (9 out of 14 patents)

5. Li Gan (8 out of 10 patents)

6. Melanie Ott (8 out of 11 patents)

7. Katerina Akassoglou (6 out of 13 patents)

8. John Newman (5 out of 31 patents)

9. Scott Michael Ulrich (5 out of 13 patents)

10. Deepak Srivastava (5 out of 9 patents)

11. Qin Xu (4 out of 4 patents)

12. Bruce Conklin (4 out of 8 patents)

13. Erik Roberson (4 out of 4 patents)

14. Karl H Weisgraber (4 out of 6 patents)

15. Robert W Mahley (3 out of 5 patents)

Core Competencies:

Genome Editing

CRISPR

HIV Treatment

Obesity Therapy

Cellular Reprogramming

Neurodegenerative Diseases

Immunodeficiency Virus

Apolipoprotein E

Robotic Microscopy

Amyloid Beta

Neuronal Repair

Lentivirus Infections

91 patents: Sort by Forward Citations

1. 12522860 - DETECTION OF GENOME EDITING (2026-01-13),

2. 12460230 - Modified mitochondrion and methods of use thereof (2025-11-04),

3. 12146166 - Generation of induced pluripotent cells by CRISPR activation (2024-11-19),

4. 11807852 - Compositions and methods for reactivating latent immunodeficiency virus (2023-11-07),

5. 11773051 - S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same (2023-10-03),

6. 11608308 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2023-03-21),

7. 11584931 - Methods and compositions for generating a deletion library and for identifying a defective interfering particle (DIP) (2023-02-21),

8. 11440948 - Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells (2022-09-13),

9. 11376242 - Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents (2022-07-05),

10. 11361527 - Automated robotic microscopy systems (2022-06-14),

11. 11236383 - Detection of genome editing (2022-02-01),

12. 11099172 - In vitro assays for inhibition of microglial activation (2021-08-24),

13. 11020463 - Method of determining cellular protein homeostasis (2021-06-01),

14. 10889538 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2021-01-12),

15. 10647658 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2020-05-12),

Company Overview

The J. David Gladstone Institutes, based in San Francisco, CA, is a leading biomedical research organization focused on advancing the understanding and treatment of various diseases through innovative genome editing techniques. The institute specializes in areas such as CRISPR technology, HIV treatment, obesity therapy, and cellular reprogramming. Its research also extends to neurodegenerative diseases and immunodeficiency viruses, aiming to develop transformative therapies that address critical health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

91 Patents

#67 in San Francisco, CA

#963 in California

#4,113 in US

#8,462 in the World

San Francisco, CA, United States of America

The J. David Gladstone Institutes

Forward Citations = 254

136 inventors:

Eric M Verdin (17 out of 23 patents)

Yadong Huang (11 out of 14 patents)

Warner C Greene (9 out of 15 patents)

4. Lennart Mucke (9 out of 14 patents)

5. Li Gan (8 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The J. David Gladstone Institutes. Retrieved from https://idiyas.com/company/j-david-gladstone-institutes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…